Generation and Characterization of Drug-Target Complex-Specific Antibodies
14 May 2019

In this application note, Bio-Rad outlines how HuCAL PLATINUM technology can generate antibody reagents that offer highly specific recognition of the drug-target complex for several approved therapeutic antibodies. Alongside type 1 and type 2 antibody reagents, these type 3 and type 4 antibodies are extremely valuable additions to the LBA toolbox and may enable the development of more sophisticated analysis tools for biotherapeutics.